Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Bernstein

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B StudyS H Bernstein, V L Brunetto, F R Davey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphomaJ H Mendler, J Kelly, S Voci, et al.
Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.
Bone Marrow Transplantation|July 5, 2001
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and reviewN I Khushalani, F G Bakri, D Wentling, et al.
British Journal of Haematology|January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancerS H Bernstein, C J Eaves, R Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factorsA Alidina, D Lawrence, L A Ford, et al.
Bone Marrow Transplantation|April 25, 2001
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinM Simon, T Hahn, L A Ford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2008
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE studyA Goy, S H Bernstein, B S Kahl, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B StudyS H Bernstein, V L Brunetto, F R Davey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphomaJ H Mendler, J Kelly, S Voci, et al.
Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.
Bone Marrow Transplantation|July 5, 2001
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and reviewN I Khushalani, F G Bakri, D Wentling, et al.
British Journal of Haematology|January 31, 1998
A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancerS H Bernstein, C J Eaves, R Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factorsA Alidina, D Lawrence, L A Ford, et al.
Bone Marrow Transplantation|April 25, 2001
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinM Simon, T Hahn, L A Ford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2008
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE studyA Goy, S H Bernstein, B S Kahl, et al.
Pageof 4